DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.33
-0.46 (-5.23%)
At close: Nov 16, 2026, 4:00 PM EST
8.35
+0.02 (0.24%)
After-hours: Nov 16, 2026, 7:30 PM EST
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $449.47 million as of November 16, 2026. It is the 14,930th most valuable company in the world and the 2,770th biggest in the United States. Its market cap has increased by 45.55% in one year.
Market Cap
449.47M
Enterprise Value
414.72M
1-Year Change
45.55%
Global Rank
Country Rank
#2,770 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $449.47M, an increase of 1,124.70%. That is a compound annual growth rate of 37.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 449.47M | 8.44% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 495.37M |
| Monopar Therapeutics | 487.93M |
| Indaptus Therapeutics | 486.85M |
| Candel Therapeutics | 486.36M |
| Phathom Pharmaceuticals | 481.35M |
| Ovid Therapeutics | 479.38M |
| Shattuck Labs | 473.57M |
| Gyre Therapeutics | 471.74M |